SG Americas Securities’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-23,029
| Closed | -$72K | – | 2657 |
|
|
2025
Q1 | $72K | Buy |
23,029
+5,195
| +29% | +$16.2K | ﹤0.01% | 2779 |
|
|
2024
Q4 | $77K | Sell |
17,834
-6,103
| -25% | -$26.4K | ﹤0.01% | 2501 |
|
|
2024
Q3 | $64K | Buy |
+23,937
| New | +$64K | ﹤0.01% | 2827 |
|
|
2022
Q2 | – | Sell |
-38,693
| Closed | -$96K | – | 3058 |
|
|
2022
Q1 | $96K | Buy |
38,693
+2,401
| +7% | +$5.96K | ﹤0.01% | 2465 |
|
|
2021
Q4 | $218K | Sell |
36,292
-15,966
| -31% | -$95.9K | ﹤0.01% | 2372 |
|
|
2021
Q3 | $348K | Buy |
+52,258
| New | +$348K | ﹤0.01% | 2577 |
|
|
2017
Q2 | – | Sell |
-471
| Closed | -$39K | – | 2695 |
|
|
2017
Q1 | $39K | Buy |
471
+324
| +220% | +$26.8K | ﹤0.01% | 2741 |
|
|
2016
Q4 | $22K | Sell |
147
-26
| -15% | -$3.89K | ﹤0.01% | 2579 |
|
|
2016
Q3 | $56K | Buy |
+173
| New | +$56K | ﹤0.01% | 2781 |
|